Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color

Affiliations

• ¹ Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
• ² Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
• ³ Harvard Medical School, Boston, Mass; Department of Dermatology, Massachusetts General Hospital, Boston, Mass.
• ⁴ Center for Drug Safety and Immunology, Departments of Medicine, Dermatology, Pharmacology, Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tenn.
• ⁵ Department of Medicine, Massachusetts General Hospital, Boston, Mass.
• ⁶ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Department of Medicine, The Mongan Institute, Massachusetts General Hospital, Boston, Mass.
• ⁷ Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
• ⁸ Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Department of Medicine, The Mongan Institute, Massachusetts General Hospital, Boston, Mass. Electronic address: kblumenthal@mgh.harvard.edu.